Anti-OX40 / CD134, clone OX-86

Anti-OX40 / CD134, clone OX-86
Item number Size Datasheet Manual SDS Delivery time Quantity Price
NSJ-V8349SAF-100UG 100 µg - -

3 - 10 business days*

752.00€
 
1 mg/ml in 1X PBS, BSA free, sodium azide free. CD134 is a type I integral membrane protein. This... more
Product information "Anti-OX40 / CD134, clone OX-86"
1 mg/ml in 1X PBS, BSA free, sodium azide free. CD134 is a type I integral membrane protein. This receptor is expressed on activated CD4+and CD8+T cells and B cells. The CD134 binds to CD134 ligand (CD252) to provide a costimulatory signal that is independent of CD28. CD134 is involved in coordinating CD4 T cell selection, migration and cytokine differentiation in T helper (Th)1 and Th2 cells. CD134 is also involved in the stimulation of T cells, T dependent humoral response and generation of optimal CD4+ T cell responses in vivo and in vitro. CD134 is expressed on activated CD4+ T lymphocytes, and its ligand, CD134L, is found preferentially on activated B cells. Engagement of CD134 with its ligand, CD134L, delivers a strong costimulatory signal to effector T cells. Protein function: Receptor for TNFSF4/OX40L/GP34. Is a costimulatory molecule implicated in long-term T-cell immunity. [The UniProt Consortium]
Keywords: Anti-Ox40, Anti-CD134, Anti-Tnfrsf4, Anti-OX40 antigen, Anti-OX40L receptor, Anti-Tumor necrosis factor receptor superfamily member 4, OX40 Antibody / CD134
Supplier: NSJ Bioreagents
Supplier-Nr: V8349SAF

Properties

Application: FC, IF
Antibody Type: Monoclonal
Clone: OX-86
Conjugate: No
Host: Rat
Species reactivity: mouse
Immunogen: Purified recombinant mouse OX40 antigen
Format: Purified

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Anti-OX40 / CD134, clone OX-86"
Write a review
or to review a product.
Viewed